Key facts
- This page summarizes John Jefferies's Form 4 filing for DAXOR CORP (DXR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 01 Sep 2026, 15:26.
John Jefferies - 28 Aug 2026 Form 4 Insider Report for DAXOR CORP (DXR)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- DXR
- Reported as of
- 28 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Sep 2026, 15:26:54 UTC
- Prior SEC filing
- 24 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Jefferies
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Jefferies filed Form 4 for DAXOR CORP (DXR) on 01 Sep 2026.
Change
- Previous filing in this sequence was filed on 24 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002086843
Primary reporting owner
Jefferies John
- Relationship
- Chief Medical Officer
- Address
- 109 MECO LANE, OAK RIDGE
- Signature
- /s/ John Jefferies
- Signature date
- 01 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DXR
transaction
Daxor Common Stock
Award
- Transaction value
- Shares
- +2,451
- Change %
- +10%
- Price
- $0.000000*
- Shares after
- 26,008
- Date
- 28 Aug 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
2,451 shares granted vest on August 28, 2026.